Last reviewed · How we verify
CYH33 for tablet
At a glance
| Generic name | CYH33 for tablet |
|---|---|
| Sponsor | Haihe Biopharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CYH33 for tablet CI brief — competitive landscape report
- CYH33 for tablet updates RSS · CI watch RSS
- Haihe Biopharma Co., Ltd. portfolio CI